Basilea Pharmaceutica AG
SIX:BSLN

Watchlist Manager

Basilea Pharmaceutica AG

SIX:BSLN

Watchlist

Price: 45.8 CHF 3.27% Market Closed

Market Cap: 552.9m CHF

Have any thoughts about
Basilea Pharmaceutica AG?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 45.8 CHF

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

BSLN Alert

Basilea Pharmaceutica AG

45.8

+1.45 (+3.27%)

52 Week Range	32.25 46.2
Price Target

We'll email you a reminder when the closing price reaches CHF.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Basilea Pharmaceutica AG

What unique competitive advantages
does Basilea Pharmaceutica AG hold over its rivals?

What risks and challenges
does Basilea Pharmaceutica AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Basilea Pharmaceutica AG.

What unique competitive advantages
does Basilea Pharmaceutica AG hold over its rivals?

What risks and challenges
does Basilea Pharmaceutica AG face in the near future?

Summarize the latest earnings call
of Basilea Pharmaceutica AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Basilea Pharmaceutica AG.

Provide P/S
for Basilea Pharmaceutica AG.

Provide P/E
for Basilea Pharmaceutica AG.

Provide P/OCF
for Basilea Pharmaceutica AG.

Provide P/FCFE
for Basilea Pharmaceutica AG.

Provide P/B
for Basilea Pharmaceutica AG.

Provide EV/S
for Basilea Pharmaceutica AG.

Provide EV/GP
for Basilea Pharmaceutica AG.

Provide EV/EBITDA
for Basilea Pharmaceutica AG.

Provide EV/EBIT
for Basilea Pharmaceutica AG.

Provide EV/OCF
for Basilea Pharmaceutica AG.

Provide EV/FCFF
for Basilea Pharmaceutica AG.

Provide EV/IC
for Basilea Pharmaceutica AG.

Show me price targets
for Basilea Pharmaceutica AG made by professional analysts.

What are the Revenue projections
for Basilea Pharmaceutica AG?

How accurate were the past Revenue estimates
for Basilea Pharmaceutica AG?

What are the Net Income projections
for Basilea Pharmaceutica AG?

How accurate were the past Net Income estimates
for Basilea Pharmaceutica AG?

What are the EPS projections
for Basilea Pharmaceutica AG?

How accurate were the past EPS estimates
for Basilea Pharmaceutica AG?

What are the EBIT projections
for Basilea Pharmaceutica AG?

How accurate were the past EBIT estimates
for Basilea Pharmaceutica AG?

Compare the revenue forecasts
for Basilea Pharmaceutica AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Basilea Pharmaceutica AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Basilea Pharmaceutica AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Basilea Pharmaceutica AG compared to its peers.

Compare the P/E ratios
of Basilea Pharmaceutica AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Basilea Pharmaceutica AG with its peers.

Analyze the financial leverage
of Basilea Pharmaceutica AG compared to its main competitors.

Show all profitability ratios
for Basilea Pharmaceutica AG.

Provide ROE
for Basilea Pharmaceutica AG.

Provide ROA
for Basilea Pharmaceutica AG.

Provide ROIC
for Basilea Pharmaceutica AG.

Provide ROCE
for Basilea Pharmaceutica AG.

Provide Gross Margin
for Basilea Pharmaceutica AG.

Provide Operating Margin
for Basilea Pharmaceutica AG.

Provide Net Margin
for Basilea Pharmaceutica AG.

Provide FCF Margin
for Basilea Pharmaceutica AG.

Show all solvency ratios
for Basilea Pharmaceutica AG.

Provide D/E Ratio
for Basilea Pharmaceutica AG.

Provide D/A Ratio
for Basilea Pharmaceutica AG.

Provide Interest Coverage Ratio
for Basilea Pharmaceutica AG.

Provide Altman Z-Score Ratio
for Basilea Pharmaceutica AG.

Provide Quick Ratio
for Basilea Pharmaceutica AG.

Provide Current Ratio
for Basilea Pharmaceutica AG.

Provide Cash Ratio
for Basilea Pharmaceutica AG.

What is the historical Revenue growth
over the last 5 years for Basilea Pharmaceutica AG?

What is the historical Net Income growth
over the last 5 years for Basilea Pharmaceutica AG?

What is the current Free Cash Flow
of Basilea Pharmaceutica AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Basilea Pharmaceutica AG.

BSLN

Cash Flow Statement

Cash from Operating Activities

Basilea Pharmaceutica AG
Cash from Operating Activities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Basilea Pharmaceutica AG
Cash from Operating Activities Peer Comparison

Comparables:

ADCT

ACIU

CRSP

IDIA

KURN

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

	Cash from Operating Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Basilea Pharmaceutica AG SIX:BSLN	Cash from Operating Activities CHf10.3m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
ADC Therapeutics SA NYSE:ADCT	Cash from Operating Activities -$118.7m	CAGR 3-Years 11%	CAGR 5-Years 0%	CAGR 10-Years N/A
AC Immune SA NASDAQ:ACIU	Cash from Operating Activities -CHf42.6m	CAGR 3-Years 14%	CAGR 5-Years N/A	CAGR 10-Years N/A
CRISPR Therapeutics AG NASDAQ:CRSP	Cash from Operating Activities -$121.8m	CAGR 3-Years N/A	CAGR 5-Years 1%	CAGR 10-Years N/A
Idorsia Ltd SIX:IDIA	Cash from Operating Activities -CHf629.3m	CAGR 3-Years -20%	CAGR 5-Years -12%	CAGR 10-Years N/A
Kuros Biosciences AG SIX:KURN	Cash from Operating Activities -CHf2.4m	CAGR 3-Years 20%	CAGR 5-Years 28%	CAGR 10-Years N/A

What is Basilea Pharmaceutica AG's Cash from Operating Activities?

Cash from Operating Activities
10.3m CHF

Based on the financial report for Jun 30, 2024, Basilea Pharmaceutica AG's Cash from Operating Activities amounts to 10.3m CHF.

What is Basilea Pharmaceutica AG's Cash from Operating Activities growth rate?

Cash from Operating Activities CAGR 1Y
-64%

Over the last year, the Cash from Operating Activities growth was -64%.

Basilea Pharmaceutica AG
SIX:BSLN

Basilea Pharmaceutica AG
Cash from Operating Activities

Basilea Pharmaceutica AG
Cash from Operating Activities Peer Comparison

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

See Also

What is Basilea Pharmaceutica AG's Cash from Operating Activities?

Cash from Operating Activities
10.3m CHF

What is Basilea Pharmaceutica AG's Cash from Operating Activities growth rate?

Cash from Operating Activities CAGR 1Y
-64%

Company

Help

Tools

Stocks

Basilea Pharmaceutica AG SIX:BSLN

Basilea Pharmaceutica AG Cash from Operating Activities

Basilea Pharmaceutica AG Cash from Operating Activities Peer Comparison

Competitive Cash from Operating Activities Analysis Latest Figures & CAGR of Competitors

See Also

What is Basilea Pharmaceutica AG's Cash from Operating Activities? Cash from Operating Activities 10.3m CHF

What is Basilea Pharmaceutica AG's Cash from Operating Activities growth rate? Cash from Operating Activities CAGR 1Y -64%

Company

Help

Tools

Stocks

Basilea Pharmaceutica AG
SIX:BSLN

Basilea Pharmaceutica AG
Cash from Operating Activities

Basilea Pharmaceutica AG
Cash from Operating Activities Peer Comparison

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

What is Basilea Pharmaceutica AG's Cash from Operating Activities?

Cash from Operating Activities
10.3m CHF

What is Basilea Pharmaceutica AG's Cash from Operating Activities growth rate?

Cash from Operating Activities CAGR 1Y
-64%